C. Vidal
About
C. Vidal is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, C. Vidal has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 23 papers in Reproductive Medicine and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in C. Vidal's work include Reproductive Biology and Fertility (17 papers), Ovarian function and disorders (16 papers) and Reproductive System and Pregnancy (11 papers). C. Vidal is often cited by papers focused on Reproductive Biology and Fertility (17 papers), Ovarian function and disorders (16 papers) and Reproductive System and Pregnancy (11 papers). C. Vidal collaborates with scholars based in Spain, United States and United Kingdom. C. Vidal's co-authors include António Pellicer, Carlos Simón, Juan Gilés, José Bellver, Ernesto Bosch, Elena Labarta, José Remohı́, Lorena Rodrigo, Sergio Cabanillas and J. Remohı́ and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
In The Last Decade
C. Vidal
42 papers receiving 1.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| C. Vidal Spain | 15 | 673 | 673 | 587 | 261 | 131 | 43 | 1.1k | ||
| Juan Gilés Spain | 13 | 466 0.7× | 628 0.9× | 451 0.8× | 204 0.8× | 114 0.9× | 34 | 985 | ||
| S.J. Morin United States | 15 | 487 0.7× | 396 0.6× | 527 0.9× | 120 0.5× | 128 1.0× | 58 | 920 | ||
| Sarah K. Darmon United States | 18 | 517 0.8× | 664 1.0× | 477 0.8× | 176 0.7× | 70 0.5× | 49 | 1.0k | ||
| Ioannis Sfontouris Greece | 19 | 934 1.4× | 874 1.3× | 655 1.1× | 84 0.3× | 61 0.5× | 40 | 1.2k | ||
| Ulun Uluğ Türkiye | 20 | 769 1.1× | 711 1.1× | 488 0.8× | 120 0.5× | 110 0.8× | 46 | 1.0k | ||
| Juana Crespo Spain | 14 | 1.3k 2.0× | 1.4k 2.0× | 609 1.0× | 239 0.9× | 79 0.6× | 27 | 1.6k | ||
| Keiichi Kato Sri Lanka | 24 | 1.2k 1.8× | 966 1.4× | 942 1.6× | 290 1.1× | 82 0.6× | 94 | 1.8k | ||
| Yannis Prapas Greece | 26 | 781 1.2× | 967 1.4× | 484 0.8× | 214 0.8× | 83 0.6× | 57 | 1.3k | ||
| J. Remohı́ Spain | 11 | 842 1.3× | 885 1.3× | 397 0.7× | 198 0.8× | 87 0.7× | 19 | 1.1k | ||
| Anne Lis Mikkelsen Denmark | 19 | 1.1k 1.7× | 1.0k 1.5× | 589 1.0× | 127 0.5× | 101 0.8× | 44 | 1.4k |
Countries citing papers authored by C. Vidal
Since
Specialization
Citations
This map shows the geographic impact of C. Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Vidal more than expected).
Fields of papers citing papers by C. Vidal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by C. Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Vidal. The network helps show where C. Vidal may publish in the future.
Co-authorship network of co-authors of C. Vidal
This figure shows the co-authorship network connecting the top 25 collaborators of C. Vidal. A scholar is included among the top collaborators of C. Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Vidal. C. Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Labarta, Elena, Cristina Rodríguez-Varela, C. Vidal, et al.. (2025). Mid-luteal serum progesterone concentrations in modified natural cycles for embryo transfer: a prospective blinded study. Reproductive BioMedicine Online. 52(2). 105171–105171.
2.
Díaz-Gimeno, Patricia, Patricia Sebastián-León, Katharina Späth, et al.. (2024). Predicting risk of endometrial failure: a biomarker signature that identifies a novel disruption independent of endometrial timing in patients undergoing hormonal replacement cycles. Fertility and Sterility. 122(2). 352–364.
3.
Quiñonero, Alicia, et al.. (2024). Oocyte Competence, Embryological Outcomes and miRNA Signature of Different Sized Follicles from Poor Responder Patients. International Journal of Molecular Sciences. 25(19). 10237–10237.
4.
Corachán, Ana, Amparo Faus, C. Vidal, et al.. (2024). Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders. Reproductive Biology and Endocrinology. 22(1). 10–10.
5.
Bellver, José, Marta Gonzáléz-Monfort, Elena Labarta, et al.. (2024). An Analysis of the Digestive and Reproductive Tract Microbiota in Infertile Women with Obesity. International Journal of Molecular Sciences. 25(23). 12600–12600.
6.
Grau-Pérez, María, Patricia Sebastián-León, Patricia Díaz-Gimeno, et al.. (2023). Association of blood cadmium and lead levels with self-reported reproductive lifespan and pregnancy loss: The national health and nutrition examination survey 1999–2018. Environmental Research. 233. 116514–116514.
7.
Díez‐Juan, Antonio, Alicia Quiñonero, Francisco Domı́nguez, et al.. (2023). The effect of vitrification on blastocyst mitochondrial DNA dynamics and gene expression profiles. Journal of Assisted Reproduction and Genetics. 40(11). 2577–2589.
8.
Gilés, Juan, María Cruz, Ana Cobo, et al.. (2023). Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy. Reproductive BioMedicine Online. 47(2). 103222–103222.
9.
Bellver, José, Carlos Marín, Ruth B. Lathi, et al.. (2021). Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation. Reproductive Sciences. 28(11). 3171–3180.
10.
Gilés, Juan, Marcos Meseguer, Amparo Mercader, et al.. (2020). Preimplantation genetic testing for aneuploidy in patients with partial X monosomy using their own oocytes: is this a suitable indication?. Fertility and Sterility. 114(2). 346–353.
11.
Díez‐Juan, Antonio, Amparo Mifsud, Amparo Mercader, et al.. (2020). Mitochondrial DNA content decreases during in vitro human embryo development: insights into mitochondrial DNA variation in preimplantation embryos donated for research. PubMed. 1(1). 36–45.
12.
Vidal, C., Juan Gilés, Nicolás Garrido, et al.. (2018). GnRH antagonist for endometrial priming in an oocyte donation programme: a prospective, randomized controlled trial. Reproductive BioMedicine Online. 37(4). 415–424.
13.
Bellver, José, María José de los Santos, Pilar Alamá, et al.. (2015). Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization. Fertility and Sterility. 103(6). 1407–1415.e1.
14.
Herrero, Javier, A. Tejera, Carmela Albert, et al.. (2013). A time to look back: analysis of morphokinetic characteristics of human embryo development. Fertility and Sterility. 100(6). 1602–1609.e4.
15.
Rubio, Carmen, José Bellver, Lorena Rodrigo, et al.. (2012). Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and Sterility. 99(5). 1400–1407.
16.
Bellver, José, Elena Labarta, Ernesto Bosch, et al.. (2009). GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial. Fertility and Sterility. 94(3). 1065–1071.
17.
Bosch, Ernesto, C. Vidal, Elena Labarta, et al.. (2008). Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study. Human Reproduction. 23(10). 2346–2351.
18.
Vidal, C., Juan Roa, L. Pinilla, António Pellicer, & Manuel Tena‐Sempere. (2008). Maternal serum ghrelin levels in early IVF pregnancies: lack of prognostic value for viable pregnancy and altered post-prandial responses. Human Reproduction. 23(4). 958–963.
19.
Simón, Carlos, Janine Oberyé, José Bellver, et al.. (2005). Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Human Reproduction. 20(12). 3318–3327.
20.
Vidal, C.. (2001). Esterilidad e infertilidad humanas. Abordaje y tratamiento. 15(8). 96–101.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Juan Gilés Breakdown of academic impact, for papers by S.J. Morin Breakdown of academic impact, for papers by Sarah K. Darmon Breakdown of academic impact, for papers by Ioannis Sfontouris Breakdown of academic impact, for papers by Ulun Uluğ Breakdown of academic impact, for papers by Juana Crespo Breakdown of academic impact, for papers by Keiichi Kato Breakdown of academic impact, for papers by Yannis Prapas Breakdown of academic impact, for papers by J. Remohı́ Breakdown of academic impact, for papers by Anne Lis Mikkelsen